NCBiotech News

Wake Forest Baptist Health and Wake Forest School of Medicine in Winston-Salem have signed a memorandum of understanding with Atrium Health to create a medical school campus in Charlotte.

For the third time since opening a Charlotte R&D and manufacturing facility in 2012, medical device company Medical Murray is celebrating the opening of an even bigger “home” in the Queen City – this one encompassing 30,000 square feet.

After more than two decades of game-changing accomplishments in the life science world, AskBio CEO Sheila Mikhail has been “discovered” as the Springboard Enterprises 2019 Northstar Honoree.

Three early stage bioscience companies in North Carolina are among 16 companies from the Southeast selected to present their funding needs to potential investors at a major industry conference next month in Florida.

Mycovia Pharmaceuticals of Durham is partnering with a major Hungarian pharmaceutical company to commercialize and manufacture one of Mycovia’s drug candidates in Europe, Latin America, Australia, Russia and other former Soviet countries.

Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has commercially launched Duaklir, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), in the United States.

Life science professionals with an interest in gastrointestinal health of either animals or humans will want to attend the North Carolina Biotechnology Center’s Animal Health & Nutrition Forum on November 4.

The NCBiotech Crop Commercialization Program was created to evaluate and coordinate the introduction and market development of newer high-value crops as well as improvements for existing crops that would help North Carolina farmers.

Over 120 life science professionals in the race for new therapies for rare disease gathered for a full late-September day of speakers, panels, audience engagement and networking at the Rare Disease Forum at the North Carolina Biotechnology Center.

How disease foundations are carving out niches and using creative models to support drug development was the focus of the first of the two-day Invest in Cures & Rare Disease Forum, hosted at the North Carolina Biotechnology Center in late September.

Farmers in the state are moving closer to a sweet new cash crop option, thanks to a research grant from the North Carolina Tobacco Trust Fund Commission to the North Carolina Biotechnology Center.

The North Carolina Biotechnology Center awarded 18 grants and loans totaling nearly $1.4 million to bioscience companies, universities and non-profit organizations in the first quarter of its 2019-20 fiscal year.

A public-private partnership has cut the ribbon for a regional industrial wastewater pretreatment facility in Clayton worth $40 million.

Aruna Bio, a Georgia pharmaceutical company with a growing Raleigh presence, has been awarded a $4.5 million grant from the National Institutes of Health to support its development of a potential stroke treatment.

Raleigh clinical-stage pharmaceutical developer Innovate Biopharma is merging with Israel-based RDD Pharma to create a new company, 9 Meters Biopharma.